Wikipedia

Indium (111In) imciromab

(redirected from Imciromab)
Indium (111In) imciromab
Monoclonal antibody
TypeFab fragment
SourceMouse
Targetcardiac myosin
Clinical data
Trade namesMyoscint
ATC code
Legal status
Legal status
  • withdrawn
Identifiers
CAS Number
ChemSpider
  • none
UNII
(verify)

Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]

See also

  • Nuclear medicine

References

  1. ^ WHO Drug Information
  2. ^ DiagnosticImaging.com: Centocor withdraws imaging agent applications


This article is copied from an article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of GNU Free Documentation License.

Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.